Literature DB >> 20665560

Nerve injury-activated microglia engulf myelinated axons in a P2Y12 signaling-dependent manner in the dorsal horn.

Mitsuyo Maeda1, Makoto Tsuda, Hidetoshi Tozaki-Saitoh, Kazuhide Inoue, Hiroshi Kiyama.   

Abstract

The mechanisms underlying neuropathic pain are poorly understood. However, several studies have implied a role for reactive microglia located in the dorsal horn in neuropathic pain. To clarify the roles of activated microglia in neuropathic pain, we investigated the interactions among microglia and other neural components in the dorsal horn using electron microscopy. Microglia were more abundantly localized in layers II-III of the dorsal horn than in other areas, and some of them adhered to and engulfed both injured and uninjured myelinated axons. This microglial engulfment was rarely observed in the normal dorsal horn, and the number of microglia attached to myelinated axons was markedly increased on postoperative day 7 on the operated side. However, after blocking the P2Y12 ATP receptor in microglia by intrathecal administration of its antagonist, AR-C69931MX, the increase in the number of microglia attached to myelinated axons, as well as the development of tactile allodynia, were markedly suppressed, although the number of activated microglia did not change remarkably. These results indicate that engulfment of myelinated axons by activated microglia via P2Y12 signaling in the dorsal horn may be a critical event in the pathogenesis of neuropathic pain.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20665560     DOI: 10.1002/glia.21053

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  29 in total

Review 1.  A brief comparison of the pathophysiology of inflammatory versus neuropathic pain.

Authors:  Qinghao Xu; Tony L Yaksh
Journal:  Curr Opin Anaesthesiol       Date:  2011-08       Impact factor: 2.706

Review 2.  Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential.

Authors:  Kazuhide Inoue; Makoto Tsuda
Journal:  Nat Rev Neurosci       Date:  2018-02-08       Impact factor: 34.870

Review 3.  ATP receptors gate microglia signaling in neuropathic pain.

Authors:  Tuan Trang; Simon Beggs; Michael W Salter
Journal:  Exp Neurol       Date:  2011-11-16       Impact factor: 5.330

Review 4.  Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain.

Authors:  Tuan Trang; Simon Beggs; Michael W Salter
Journal:  Neuron Glia Biol       Date:  2012-05-22

5.  IRF8 is a transcriptional determinant for microglial motility.

Authors:  Takahiro Masuda; Nao Nishimoto; Daisuke Tomiyama; Tsuyoshi Matsuda; Hidetoshi Tozaki-Saitoh; Tomohiko Tamura; Shinichi Kohsaka; Makoto Tsuda; Kazuhide Inoue
Journal:  Purinergic Signal       Date:  2014-05-07       Impact factor: 3.765

Review 6.  P2X4 purinoceptor signaling in chronic pain.

Authors:  Tuan Trang; Michael W Salter
Journal:  Purinergic Signal       Date:  2012-04-15       Impact factor: 3.765

Review 7.  Neuroprotective roles of the P2Y(2) receptor.

Authors:  Gary A Weisman; Deepa Ajit; Richard Garrad; Troy S Peterson; Lucas T Woods; Christina Thebeau; Jean M Camden; Laurie Erb
Journal:  Purinergic Signal       Date:  2012-04-14       Impact factor: 3.765

8.  Microglial P2Y12 receptors regulate microglial activation and surveillance during neuropathic pain.

Authors:  Nan Gu; Ukpong B Eyo; Madhuvika Murugan; Jiyun Peng; Sanjana Matta; Hailong Dong; Long-Jun Wu
Journal:  Brain Behav Immun       Date:  2015-11-11       Impact factor: 7.217

Review 9.  The role of transcription-independent damage signals in the initiation of epithelial wound healing.

Authors:  João V Cordeiro; António Jacinto
Journal:  Nat Rev Mol Cell Biol       Date:  2013-02-27       Impact factor: 94.444

Review 10.  Inhibition of microglia activation as a phenotypic assay in early drug discovery.

Authors:  Mariana Figuera-Losada; Camilo Rojas; Barbara S Slusher
Journal:  J Biomol Screen       Date:  2013-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.